Tsuchida Yasue

Researcher

基本情報

Profile and Settings

• 氏名

  Tsuchida Yasue

Affiliation

• Breast Surgical Oncology, Assistant Professor

Location

• University Hospital

Achievements

Published Papers

• 【日常診療での超音波検査のおさえどころ】日常診療での超音波検査　乳腺, 土田 寧恵;林 直輝, 臨牀と研究, 101(7):824, Jul. 2024
• 当院における周術期免疫チェックポイント阻害剤使用の実際と今後の展望, 中山 紗由香;増田 紘子;土田 寧恵;垂野 香苗;小原 淳;林 直輝, 日本乳癌学会総会プログラム抄録集, 32回:308, Jul. 2024, Peer-reviewed
• Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in Japan., Tsuchida Yasue;Niikura Naoki;Chishima Takashi;Mizuno Mari;Kawate Takahiko;Fuchikami Hiromi;Miyoshi Yasuo;Sakai Takehiko;Kotani Haruru;Kondo Naoto;Hayashi Naoki, Breast cancer (Tokyo, Japan), 31(3), Mar. 2024, Peer-reviewed, DOI:10.1007/s12282-024-01548-8
• Sarcoidosis or sarcoid-like reaction with mediastinal lymphadenopathy in patients after breast cancer surgery, Ryosuke Imai, Yasue Tsuchida, Torahiko Jinta, Respir Investig, 61(4):398 - 404, Jul. 2023, Peer-reviewed, DOI:10.1016/j.resinv.2023.03.008. Epub 2023 Apr 24.
• 早期乳癌におけるLAMP法を用いた25遺伝子発現プロファイリングの臨床的有用性(Clinical utility of twenty-five gene-expression profiling using LAMP method in early stage breast cancer), 土田 寧恵;上田 隆晶;長竹 由佳;道行 悟;服部 未来;佐藤 正樹;富田 憲弘;鹿股 直樹;山内 英子, 日本乳癌学会総会プログラム抄録集, 31回:66, Jun. 2023, Peer-reviewed
• COMPLETE RESPONSE TO TRASTUZUMAB AND PERTUZUMAB IN COMBINATION WITH CHEMOTHERAPY IN HER2-POSITIVE METASTATIC BREAST CANCER―CASE SERIES―, 土田寧恵, 林直輝, 利川千絵, 山下祐司, 鈴木高祐, 山内英子, 日臨外会誌, 80(3):480 - 485, Mar. 2019, Peer-reviewed

Presentations

• Clinical utility of 25 gene-expression profiling using LAMP method in early-stage breast cancer, Yasue Tsuchida, Takaaki Ueda, Yuka Nagatake, Satoru Michiyuki, Miku Hattori, Masaki Sato, Norihiro Tomita, Naoki Kanomata, and Hideko Yamauchi, The 31st Annual Meeting of the Japanese Breast Cancer Society, Jul. 2023
• 高齢者乳がん患者への治療マネジメント, 土田寧恵, 山内英子, 第83回 日本臨床外科学会総会, Nov. 2022
• 多施設データに基づくOncotypeDX®検査による術後治療の選択と予後との相関, 土田 寧恵, 新倉 直樹, 千島 隆司, 水野 万里, 河手 敬彦, 渕上 ひろみ, 三好 康雄6, 坂井 威彦, 小谷 はるる, 近藤　直人, 林 直輝, 第30回 日本乳癌学会学術総会, Jul. 2022
• A validated model to predict low recurrence risk distinguished by 21 gene recurrence score in hormone receptor positive invasive breast cancer patients., Yasue Tsuchida, Sachiko Ohde, Ryota Nakamura, Yoko Kanada, Sakiko Miura, Masafumi Takimoto, Seigo Nakamura, Naoki Kanomata, Hideko Yamauchi, and Naoki Hayashi, American Society of Clinical Oncology, May 2021
• Undertreatment of Breast cancer in geriatric patients, Yasue Tsuchida, Hideko Yamauchi, Global Breast Cancer Conference, Apr. 2021
• Clinical Utility of Adding 21-Gene Recurrence Score to Standard Treatment Decisions in Early-Stage Hormone Receptor-Positive Breast Cancer, Yasue Tsuchida, Naoki Hayashi, Mamika Nakamura, Maki Namura1, Kousuke Suzuki, Seigo Nakamura, Hideko Yamauchi, 第26回 日本乳癌学会学術総会, Jul. 2018
• A model to predict low recurrence risk distinguished by 21-gene Recurrence Score in estrogen receptor-positive invasive breast cancer patients, Yasue Tsuchida, Naoki Hayashi, Fumio Omata, Sachiyo Ohde, Koyu Suzuki, Masafumi Takimoto, Seigo Nakamura, Hideko Yamauchi, European Society For Medical Oncology Asia, Nov. 2017
• Clinical utility of adding 21-gene recurrence score to standard treatment decisions in early-stage hormone receptor-positive breast cancer, Yasue Tsuchida, Naoki Hayashi, Mamika Nakamura, Maki Namura, Kousuke Suzuki, Seigo Nakamura, Hideko Yamauchi1, 3rd World Congress on Controversies in Breast Cancer 2017, Oct. 2017
• Predictive value of the 21-gene Recurrence Score for Invasive lobular carcinoma, Mamika Nakamura, Maki Namura, Yasue Tsuchida, Koyu Suzuki, Seigo Nakamura, Hideko Yamauchi, Naoki Hayashi, 3rd World Congress on Controversies in Breast Cancer, Tokyo, Japan, Oct. 2017
• Clinicopathological predictors for low risk recurrence distinguished by 21-gene recurrence score in estrogen receptor positive invasive breast cancer, Yasue Tsuchida, Naoki Hayashi , Fumio Omata , Koyu Suzuki, Hideko Yamauchi, San Antonio Breast Cancer Symposium, Dec. 2016

Research Projects

• Biomarker for neoadjuvant chemotherapy for breast cancer using T-cell receptor leptore analysis., Yasue Tsuchida, Japan Society for the Promotion of Science, 25K11914, From 20250401